Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel

International Journal of Biological Markers

Volumn 19, Issue 2, 2004, Pages 120-129

  Caserman, S ^a   Lah, Tamara T ^a  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

Angiogenesis; Batimastat; Cathepsin B; Cathepsin L; Cysteine proteinase; Cysteine proteinase inhibitors; Gelatinase A; Matrix metalloproteinase 2

Indexed keywords

CATHEPSIN B; CATHEPSIN L; COLLAGEN GEL; GELATINASE A; MESSENGER RNA;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; EXPLANT; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASCULAR RING;

EID: 4243102949     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080401900206     Document Type: Article

References (46)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
3. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Intl Biochem Cell Biol 2001; 33: 960-70.
4. Noel A, Foidart JM. Role of serine proteases and their inhibitors in tumour growth and angiogenesis. In: Foidar J-M, Muschel RJ, eds. Proteases and their inhibitors in cancer metastasis. London: Kluwer Academic Press, 2002; 23-38.
5. Pepper MS, Montesano R, Mandriota SJ, et al. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 1996; 49: 138-62.
6. Turk V, Turk B, Guncar G, et al. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv Enzyme Regul 2002; 42: 285-303.
7. Lah TT, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998; 379: 125-130.
8. Divya, Chhikara P, Mahajan VS, Datta Gupta S, Chauhan SS. Differential activity of cathepsin L in human placenta at two different stages of gestation. Placenta 2002; 23: 59-64.
9. Kakegawa H, Tagami K, Ohba Y, et al. Secretion and processing mechanisms of procathepsin L in bone resorption. FEBS Lett 1995; 370: 78-82.
10. Robker RL, Russell DL, Espey LL, et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A 2000; 97: 4689-94.
11. Cunnane G, FitzGerald O, Hummel KM, et al. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology (Oxford) 1999; 38: 34-42.
12. Afonso S, Romagnano L, Babiarz B. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development 1997; 124: 3415-25.
13. Afonso S, Romagnano L, Babiarz B. Expression of cathepsin proteinases by mouse trophoblast in vivo and in vitro. Dev Dyn 1999; 216: 374-84.
14. Alexander CM, Hansell EJ, Behrendtsen O, et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996; 122: 1723-36.
15. Tanaka SS, Togooka Y, Sato H, Seiki M, Tojo H, Tachi C. Expression and localization of membrane type matrix metalloproteinase-1 (MT1-MMP) in trophoblast cells of cultured mouse blastocysts and ectoplacental cones. Placenta 1998; 19: 41-8.
16. Eeckhout Y, Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977; 166: 21-31.
17. Kobayashi H, Schmitt M, Goretzki L, et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem 1991; 266: 5147-52.
18. Goretzki L, Schmitt M, Mann K, et al. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L. FEBS Lett 1992; 297: 112-8.
19. Schmitt M, Jaenicke F, Graeff H. Proteases, matrix degradation and tumour cell spread. Fibrinolysis 1992; 6: 1-17.
20. Kostoulas G, Lang A, Nagase H, et al. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 1999; 455: 286-90.
21. Strojnik T, Kos J, Zidanik B, et al. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 1999; 5: 559-67.
22. Keppler D, Sameni M, Moin K, et al. Tumor progression and angiogenesis: cathepsin B & Co. Biochem Cell Biol 1996; 74: 799-810.
23. Sinha AA, Gleason DF, Staley NA, et al. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat Rec 1995; 241: 353-62.
24. Lah TT, Kalman E, Najjar D, et al. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis. Hum Pathol 2000; 31: 149-60.
25. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7: 14-23.
26. Brooks PC, Silletti S, von Schalscha TL, et al. Disruption of angiogenesis by PEX, a noncatalytic metal loproteinase fragment with integrin binding activity. Cell 1998; 92: 391-400.
27. Zhu WH, Guo X, Villaschi S, et al. Regulation of vascular growth and regression by matrix metal loproteinases in the rat aorta model of angiogenesis. Lab Invest 2000; 80: 545-55.
28. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990; 63: 115-22.
29. Zhu WH, Nicosia RF. The thin prep rat aortic ring assay: a modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 2002; 5: 81-6.
30. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 1972; 54: 626-37.
31. Arora S, Chauhan SS. Identification and characterization of a novel human cathepsin L splice variant. Gene 2002; 293: 123-31.
32. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856-62.
33. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21: 1104-17.
34. Mikkelsen T, Yan PS, Ho KL, et al. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 1995; 83: 285-90.
35. Koblinski JE, Dosescu J, Sameni M, et al. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem 2002; 277: 32220-7.
36. Shi GP, Sukhova GK, Kuzuya M, et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003; 92: 493-500.
37. Patan S, Munn LL, Jain RK. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res 1996; 51: 260-72.
38. Felbor U, Dreier L, Bryant RA, et al. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000; 19: 1187-94.
39. Sounni NE, Devy L, Hajitou A, et al. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 2002; 16: 555-64.
40. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 1990; 26: 119-28.
41. Nicosia RF, Lin YJ, Hazelton D, et al. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am J Pathol 1997; 151: 1379-86.
42. Villaschi S, Nicosia RF. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993; 143: 181-90.
43. Haas TL, Davis SJ, Madri JA. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 1998; 273: 3604-3610.
44. Lamoreaux WJ, Fitzgerald ME, Reiner A, et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998; 55: 29-42.
45. Unemori EN, Ferrara N, Bauer EA, et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-62.
46. Zhang J, Cao YJ, Li FY, et al. Effects of fibronectin, VEGF and angiostatin on the expression of MMPs through different signaling pathways in the JEG-3 cells. Am J Reprod Immunol 2003; 50: 273-85.